Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET MJ Reinhardt, C Ehritt-Braun, D Vogelgesang, C Ihling, S Högerle, ... Radiology 218 (3), 776-782, 2001 | 421 | 2001 |
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer I Brink, T Schumacher, M Mix, S Ruhland, E Stoelben, W Digel, M Henke, ... European journal of nuclear medicine and molecular imaging 31, 1614-1620, 2004 | 281 | 2004 |
Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events TH Schindler, EU Nitzsche, HR Schelbert, M Olschewski, J Sayre, M Mix, ... Journal of the American College of Cardiology 45 (9), 1505-1512, 2005 | 164 | 2005 |
FDG-PET imaging for the staging and follow-up of small cell lung cancer T Schumacher, I Brink, M Mix, M Reinhardt, G Herget, W Digel, M Henke, ... European journal of nuclear medicine 28, 483-488, 2001 | 161 | 2001 |
Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison … C Zamboglou, V Drendel, CA Jilg, HC Rischke, TI Beck, ... Theranostics 7 (1), 228, 2017 | 159 | 2017 |
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ... The Lancet Oncology 21 (4), 581-592, 2020 | 152 | 2020 |
Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences A Imdahl, MJ Reinhardt, EU Nitzsche, M Mix, A Dingeldey, A Einert, ... Langenbeck's Archives of Surgery 385, 129-134, 2000 | 120 | 2000 |
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate-and high-risk prostate cancer-a … C Zamboglou, M Carles, T Fechter, S Kiefer, K Reichel, TF Fassbender, ... Theranostics 9 (9), 2595, 2019 | 115 | 2019 |
68Ga-HBED-CC-PSMA PET/CT versus histopathology in primary localized prostate cancer: a voxel-wise comparison C Zamboglou, F Schiller, T Fechter, G Wieser, CA Jilg, A Chirindel, ... Theranostics 6 (10), 1619, 2016 | 112 | 2016 |
Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short-and long-term vitamin C … TH Schindler, EU Nitzsche, T Munzel, M Olschewski, I Brink, M Jeserich, ... Journal of the American College of Cardiology 42 (5), 814-822, 2003 | 108 | 2003 |
Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors TH Schindler, EU Nitzsche, M Olschewski, N Magosaki, M Mix, JO Prior, ... Circulation 110 (9), 1069-1075, 2004 | 103 | 2004 |
Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy T Shepherd, M Teras, RR Beichel, R Boellaard, M Bruynooghe, V Dicken, ... IEEE transactions on medical imaging 31 (11), 2006-2024, 2012 | 101 | 2012 |
PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography TH Schindler, EU Nitzsche, M Olschewski, I Brink, M Mix, J Prior, A Facta, ... Journal of Nuclear Medicine 45 (3), 419-428, 2004 | 101 | 2004 |
Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome NE Wiedenmann, S Bucher, M Hentschel, M Mix, W Vach, MI Bittner, ... Radiotherapy and oncology 117 (1), 113-117, 2015 | 89 | 2015 |
Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy MI Bittner, N Wiedenmann, S Bucher, M Hentschel, M Mix, WA Weber, ... Radiotherapy and Oncology 108 (3), 511-516, 2013 | 82 | 2013 |
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA)–protocol of a randomized phase II trial (NOA 10/ARO 2013-1) O Oehlke, M Mix, E Graf, T Schimek-Jasch, U Nestle, I Götz, ... BMC cancer 16, 1-10, 2016 | 74 | 2016 |
Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma I Brink, M Hentschel, TA Bley, A Walch, M Mix, M Kleimaier, E Moser, ... European Journal of Surgical Oncology (EJSO) 30 (5), 544-550, 2004 | 74 | 2004 |
Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent … TH Schindler, E Nitzsche, N Magosaki, I Brink, M Mix, M Olschewski, ... Heart 89 (5), 517-526, 2003 | 58 | 2003 |
Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? EU Nitzsche, S Hoegerle, M Mix, I Brink, A Otte, E Moser, A Imdahl European journal of nuclear medicine and molecular imaging 29, 237-242, 2002 | 55 | 2002 |
Radiation and systemic therapy for limited-stage small-cell lung cancer JA Bogart, SN Waqar, MD Mix Journal of Clinical Oncology 40 (6), 661, 2022 | 54 | 2022 |